| PMC full text: | Published online 2014 Feb 10. doi: 10.1186/2045-709X-22-9
|
Table 5
Consensus items identified during the Delphi process ranked hierarchically in order of importance
| Rank | Important | Voted most important item (%) 1 | |
|---|---|---|---|
| 1 | Cost-effectiveness/economic evaluations | 34 | |
| 2 | Identification of subgroups likely to respond to treatment | 17 | |
| 3 | Initiation and promotion of collaborative research efforts | 10 | |
| 4 | Promotion of chiropractors to obtain PhD’s | 5 | |
| 5 | | i. Dose response and frequency of treatment | 2 |
| | | ii. Biopsychosocial variables as predictors of outcome | 0 |
| | | iii. Anatomical &/or neurophysiological basis of chiropractic treatment on MSK pain | 7 |
| 8 | Effects and response of treatment on function and performance | 0 | |
| 9 | Establishing clinical research networks throughout Europe | 5 | |
| 10 | Prevention of MSK pain in primary and secondary care | 7 | |
| 11 | Effects and response of treatment on quality of life | 2 | |
| 12 | Effects and response of treatment on MSK pain | 5 | |
| 13 | Clinical findings as predictors of outcome | 0 | |
| 14 | | i. Treatment and effects in adolescents | 2 |
| | | ii. Prognostic research on the clinical course of MSK pain | 0 |
| 16 | Treatment and effects in a working population, prevention in injured workers | 2 | |
| 17 | | i. Long-term effects of treatment | 0 |
| | | ii. Treatment and effects in geriatrics | 0 |
| 19 | Prevalence, incidence and prevention of MSK conditions in a working population | 0 | |
Abbreviations:MSK musculoskeletal.
1Percentage of the participants that voted the given consensus item as most important (i.e. number one priority).
Note: No items were found to be unimportant or of uncertain importance. Items that are indented received equal numbers of votes.